1253 BMP Regulatory Activity is Enabled by Glycosylation of Twisted gastrulation

Saturday, March 24, 2012: 9:45 a.m. - 11 a.m.
Presentation Type: Poster Session
C.J. BILLINGTON JR.1, J.E. FIEBIG2, C.L. FORSMAN1, L. PHAM3, N. BURBACH4, M. SUN5, T. JASKOLL6, K. MANSKY4, R. GOPALAKRISHNAN7, M.B. O'CONNOR8, T.D. MUELLER2, and A. PETRYK1, 1Pediatrics and Genetics Cell Biology and Development, University of Minnesota, Minneapolis, MN, 2Department for Molecular Plant Physiology and Biophysics, University of Wuerzburg, Wuerzburg, Germany, 3University of Minnesota, St. Paul, MN, 4University of Minnesota, Minneapolis, MN, 5Neurodegeneration Discovery Performance Unit, GlaxoSmithKline Research & Development, Shanghai, China, 6Laboratory for Developmental Genetics, University of Southern California, Los Angeles, CA, 7Oral & Maxillofacial Pathology, University of Minnesota, Minneapolis, MN, 8Genetics Cell Biology and Development, University of Minnesota, Minneapolis, MN
Objectives: Bone Morphogenetic Proteins (BMPs) are key regulators of bone development and are increasingly used in clinical settings to improve fracture healing and fixation of implanted structures. Despite this emerging use, understanding of the regulation of BMP functions remains limited. Twisted gastrulation (TWSG1) is an extracellular BMP binding protein, which serves to modulate BMP signaling. Mice carrying deletion of exon 4 of TWSG1 have a range of craniofacial defects, including micrognathia and agnathia as well as osteopenia. We hypothesized that glycosylation of TWSG1 plays a key role in the interaction with BMPs and regulating their activity.

Methods: Glycosylation sites in TWSG1 were predicted using the EnsemblGly software and confirmed by site-directed mutagenesis and enzymatic deglycosylation, followed by western blotting. Interaction of BMPs with TWSG1 was assayed by immunoprecipitation with wild type TWSG1 and TWSG1 that had mutated or absent glycosylation sites. Non-glycosylated and glycosylated recombinant TWSG1 proteins were generated in bacterial and insect cell expression systems, respectively, and assayed quantitatively for BMP binding using surface plasmon resonance analysis. A mandibular explant culture system was used to examine the effect of these TWSG1 proteins on the expression of the BMP target gene Msx2.

Results: TWSG1 in mice has two glycosylation sites, which are both encoded by the fourth exon. Deletion of the entire exon 4 or mutation of both glycosylation sites abolishes glycosylation of mTWSG1. Constructs with mutated glycosylation sites have significantly reduced BMP binding activity. A non-glycosylated form of the protein binds to BMPs with approximately 10-fold reduced affinity compared to the glycosylated form. The non-glycosylated form of TWSG1 is unable to suppress Msx2 expression in mandibular explants, while glycosylated forms do suppress Msx2.

Conclusions: We report that glycosylation is essential for normal action of TWSG1 and hence may represent an important variable in the regulation of BMP signaling.

This abstract is based on research that was funded entirely or partially by an outside source: NIGMS T32GM008244 NIAMS T32AR050938 NIDCR T32DE007288 NIDCR R01DE016601

Keywords: Bone, Bone repair, Embryology, Gene expression and Growth & development